National Academies Press: OpenBook

Ovarian Cancers: Evolving Paradigms in Research and Care (2016)

Chapter: Appendix D: Workshop Agendas

« Previous: Appendix C: Open and Active Clinical Trials on Epithelial Ovarian Cancer
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×

Appendix D

Workshop Agendas

JANUARY 8, 2015

The Keck Center of the National Academies
500 Fifth Street, NW,
Washington, DC 20001

 
1:00 p.m. Welcome study sponsors and introductory remarks
Jerome F. Strauss III (Committee Chair)
Virginia Commonwealth University School of Medicine

Lisa Richardson
Centers for Disease Control and Prevention

Discussion and Q&A
 
2:00 p.m. Invited statements from stakeholders
Calaneet Balas
Ovarian Cancer National Alliance

Comments from other public attendees
 
2:30 p.m. Summary and adjournment of public session
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×

APRIL 7, 2015

The Keck Center of the National Academies
500 Fifth Street, NW,
Washington, DC 20001

 
8:45 a.m. Welcome and opening remarks; introduction of committee
Jerome F. Strauss III (Committee Chair)
Virginia Commonwealth University School of Medicine
 
TOPIC #1: THE BIOLOGY OF OVARIAN CANCER
9:00 a.m. Introductions
Douglas A. Levine (Moderator)
Memorial Sloan Kettering Cancer Center
 
9:05 a.m. Series of presentations

Cell of origin: Stem cells
Alexander Nikitin
Cornell University

Cell of origin: Fallopian tubes
Ronny Drapkin
University of Pennsylvania

Genetics/Single-Nucleotide Polymorphisms
Simon Gayther
University of Southern California
 
9:50 a.m. Discussion with committee
 
TOPIC #2: SCREENING AND EARLY DETECTION
10:50 a.m. Introductions
Shelley S. Tworoger (Moderator)
Harvard Medical School/Harvard School of Public Health/Brigham and Women’s Hospital
 
10:55 a.m. Series of presentations

Risk factors and biomarkers by histologic subtypes
Nicolas Wentzensen
National Cancer Institute
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×
Imaging-based diagnostics for early detection
Martin McIntosh
Fred Hutchinson Cancer Research Center

Design of screening trials
Christine Berg
Johns Hopkins Medicine
 
11:40 a.m. Discussion with committee
 
TOPIC #3: NOVEL TREATMENTS
1:15 p.m. Introductions
Anil K. Sood (Moderator)
The University of Texas MD Anderson Cancer Center
 
1:20 p.m. Series of presentations

Challenges of development of novel therapeutics in ovarian cancer
Tony Ho
AstraZeneca

Nonpharmacologic approaches
Melinda Irwin
Yale University

Targeting p53
Guillermina Lozano
The University of Texas MD Anderson Cancer Center
 
2:05 p.m. Discussion with committee
 
TOPIC #4: SURVIVORSHIP
3:00 p.m. Introductions
Heidi Donovan (Moderator)
University of Pittsburgh School of Nursing
 
3:05 p.m. Series of presentations

Biobehavioral pathways in epithelial ovarian cancer
Susan Lutgendorf
University of Iowa
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×
 
Quality of life and supportive care
Lari Wenzel
University of California, Irvine

Dissemination and implementation of evidence-based strategies
Karen Emmons
Kaiser Permanente
 
3:50 p.m. Discussion with committee
 
4:30 p.m. Open comment period
 
5:00 p.m. Adjourn
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×
Page 363
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×
Page 364
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×
Page 365
Suggested Citation:"Appendix D: Workshop Agendas." National Academies of Sciences, Engineering, and Medicine. 2016. Ovarian Cancers: Evolving Paradigms in Research and Care. Washington, DC: The National Academies Press. doi: 10.17226/21841.
×
Page 366
Next: Appendix E: Committee and Staff Biographies »
Ovarian Cancers: Evolving Paradigms in Research and Care Get This Book
×
Buy Paperback | $75.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

In an era of promising advances in cancer research, there are considerable and even alarming gaps in the fundamental knowledge and understanding of ovarian cancer. Researchers now know that ovarian cancer is not a single disease--several distinct subtypes exist with different origins, risk factors, genetic mutations, biological behaviors, and prognoses. However, persistent questions have impeded progress toward improving the prevention, early detection, treatment, and management of ovarian cancers. Failure to significantly improve morbidity and mortality during the past several decades is likely due to several factors, including the lack of research being performed by specific disease subtype, lack of definitive knowledge of the cell of origin and disease progression, and incomplete understanding of genetic and non-genetic risk factors.

Ovarian Cancers examines the state of the science in ovarian cancer research, identifies key gaps in the evidence base and the challenges to addressing those gaps, considers opportunities for advancing ovarian cancer research, and examines avenues for translation and dissemination of new findings and communication of new information to patients and others. This study makes recommendations for public- and private-sector efforts that could facilitate progress in reducing the incidence of morbidity and mortality from ovarian cancers.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!